insights_auto
Why is SABS down 3,94%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
3,07 $
arrow_downward
-3,94%(-0,13) 1D
19 նոյ, 14:55:14 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
3,20 $
High
3,21 $
Low
3,04 $
Mkt. cap
276,93 մլն
Avg. vol.
689,33 հզր
Volume
145,32 հզր
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 մլն
No. of employees
86
Open
3,20 $
High
3,21 $
Low
3,04 $
Mkt. cap
276,93 մլն
Avg. vol.
689,33 հզր
Volume
145,32 հզր
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 մլն
No. of employees
86
News stories
From web sources and news partners
Investing.com
·
2 օր առաջ
SAB Biotherapeutics at UBS conference: late-stage diabetes bet
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersՄայամի Բիչ, Ֆլորիդա, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitesab.bio